DYZ-2-90, a Novel Neo-tanshinlactone Ring-Opened Compound, Induces ERK-Mediated Mitotic Arrest and Subsequent Apoptosis by Activating JNK in Human Colorectal Cancer Cells

Li Ting Wang, Shiow Lin Pan, Tzu Hsuan Chen, Yizhou Dong, Kuo Hsiung Lee, Che Ming Teng

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Over the past several decades, there has been a considerable and still growing interest in discovering natural products with anticancer potential from traditional Chinese medicine and increasing their anticancer selectivity by chemical modification. In addition, total synthesis of active compounds from natural products can overcome problems related to poor resource availability. DYZ-2-90 is a novel ring-opened compound modified from neo-tanshinlactone, which is isolated from Chinese medicinal herb tanshen. Both in vitro and in vivo tubulin polymerization assays showed that DYZ-2-90 directly bound to microtubules and rapidly induced tubulin depolymerization, inducing ERK-mediated mitotic arrest and subsequent apoptosis by JNK activation in cancer cells, respectively. These results suggest that the fate of cells that undergo mitotic arrest is dictated by two competing networks activated by DYZ-2-90: the cytoprotective ERK pathway and the stress-related JNK pathway. DYZ-2-90 is therefore a novel microtubule-destabilizing agent and a new drug candidate for cancer therapy. This paper provides a new insight into the model of mitotic cell death, which was proposed in order to elucidate how cancer cells respond to microtubule-interfering agents and prolonged cell cycle delay.

Original languageEnglish
Pages (from-to)1663-1672
Number of pages10
JournalChemBioChem
Volume13
Issue number11
DOIs
Publication statusPublished - Jul 23 2012

Fingerprint

Colorectal Neoplasms
Cells
Microtubules
Apoptosis
MAP Kinase Signaling System
Tubulin
Biological Products
Neoplasms
Depolymerization
Bioelectric potentials
Chinese Traditional Medicine
Chemical modification
Cell death
Medicinal Plants
Polymerization
Medicine
Assays
Cell Cycle
Cell Death
Chemical activation

Keywords

  • Apoptosis
  • ERK
  • JNK
  • Microtubules
  • Mitotic arrest
  • Natural products

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

DYZ-2-90, a Novel Neo-tanshinlactone Ring-Opened Compound, Induces ERK-Mediated Mitotic Arrest and Subsequent Apoptosis by Activating JNK in Human Colorectal Cancer Cells. / Wang, Li Ting; Pan, Shiow Lin; Chen, Tzu Hsuan; Dong, Yizhou; Lee, Kuo Hsiung; Teng, Che Ming.

In: ChemBioChem, Vol. 13, No. 11, 23.07.2012, p. 1663-1672.

Research output: Contribution to journalArticle

@article{aae5c98b513140d6967b2ec8e665446b,
title = "DYZ-2-90, a Novel Neo-tanshinlactone Ring-Opened Compound, Induces ERK-Mediated Mitotic Arrest and Subsequent Apoptosis by Activating JNK in Human Colorectal Cancer Cells",
abstract = "Over the past several decades, there has been a considerable and still growing interest in discovering natural products with anticancer potential from traditional Chinese medicine and increasing their anticancer selectivity by chemical modification. In addition, total synthesis of active compounds from natural products can overcome problems related to poor resource availability. DYZ-2-90 is a novel ring-opened compound modified from neo-tanshinlactone, which is isolated from Chinese medicinal herb tanshen. Both in vitro and in vivo tubulin polymerization assays showed that DYZ-2-90 directly bound to microtubules and rapidly induced tubulin depolymerization, inducing ERK-mediated mitotic arrest and subsequent apoptosis by JNK activation in cancer cells, respectively. These results suggest that the fate of cells that undergo mitotic arrest is dictated by two competing networks activated by DYZ-2-90: the cytoprotective ERK pathway and the stress-related JNK pathway. DYZ-2-90 is therefore a novel microtubule-destabilizing agent and a new drug candidate for cancer therapy. This paper provides a new insight into the model of mitotic cell death, which was proposed in order to elucidate how cancer cells respond to microtubule-interfering agents and prolonged cell cycle delay.",
keywords = "Apoptosis, ERK, JNK, Microtubules, Mitotic arrest, Natural products",
author = "Wang, {Li Ting} and Pan, {Shiow Lin} and Chen, {Tzu Hsuan} and Yizhou Dong and Lee, {Kuo Hsiung} and Teng, {Che Ming}",
year = "2012",
month = "7",
day = "23",
doi = "10.1002/cbic.201200191",
language = "English",
volume = "13",
pages = "1663--1672",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",
number = "11",

}

TY - JOUR

T1 - DYZ-2-90, a Novel Neo-tanshinlactone Ring-Opened Compound, Induces ERK-Mediated Mitotic Arrest and Subsequent Apoptosis by Activating JNK in Human Colorectal Cancer Cells

AU - Wang, Li Ting

AU - Pan, Shiow Lin

AU - Chen, Tzu Hsuan

AU - Dong, Yizhou

AU - Lee, Kuo Hsiung

AU - Teng, Che Ming

PY - 2012/7/23

Y1 - 2012/7/23

N2 - Over the past several decades, there has been a considerable and still growing interest in discovering natural products with anticancer potential from traditional Chinese medicine and increasing their anticancer selectivity by chemical modification. In addition, total synthesis of active compounds from natural products can overcome problems related to poor resource availability. DYZ-2-90 is a novel ring-opened compound modified from neo-tanshinlactone, which is isolated from Chinese medicinal herb tanshen. Both in vitro and in vivo tubulin polymerization assays showed that DYZ-2-90 directly bound to microtubules and rapidly induced tubulin depolymerization, inducing ERK-mediated mitotic arrest and subsequent apoptosis by JNK activation in cancer cells, respectively. These results suggest that the fate of cells that undergo mitotic arrest is dictated by two competing networks activated by DYZ-2-90: the cytoprotective ERK pathway and the stress-related JNK pathway. DYZ-2-90 is therefore a novel microtubule-destabilizing agent and a new drug candidate for cancer therapy. This paper provides a new insight into the model of mitotic cell death, which was proposed in order to elucidate how cancer cells respond to microtubule-interfering agents and prolonged cell cycle delay.

AB - Over the past several decades, there has been a considerable and still growing interest in discovering natural products with anticancer potential from traditional Chinese medicine and increasing their anticancer selectivity by chemical modification. In addition, total synthesis of active compounds from natural products can overcome problems related to poor resource availability. DYZ-2-90 is a novel ring-opened compound modified from neo-tanshinlactone, which is isolated from Chinese medicinal herb tanshen. Both in vitro and in vivo tubulin polymerization assays showed that DYZ-2-90 directly bound to microtubules and rapidly induced tubulin depolymerization, inducing ERK-mediated mitotic arrest and subsequent apoptosis by JNK activation in cancer cells, respectively. These results suggest that the fate of cells that undergo mitotic arrest is dictated by two competing networks activated by DYZ-2-90: the cytoprotective ERK pathway and the stress-related JNK pathway. DYZ-2-90 is therefore a novel microtubule-destabilizing agent and a new drug candidate for cancer therapy. This paper provides a new insight into the model of mitotic cell death, which was proposed in order to elucidate how cancer cells respond to microtubule-interfering agents and prolonged cell cycle delay.

KW - Apoptosis

KW - ERK

KW - JNK

KW - Microtubules

KW - Mitotic arrest

KW - Natural products

UR - http://www.scopus.com/inward/record.url?scp=84863990784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863990784&partnerID=8YFLogxK

U2 - 10.1002/cbic.201200191

DO - 10.1002/cbic.201200191

M3 - Article

C2 - 22761044

AN - SCOPUS:84863990784

VL - 13

SP - 1663

EP - 1672

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

IS - 11

ER -